L

Labiana Health SA
MAD:LAB

Watchlist Manager
Labiana Health SA
MAD:LAB
Watchlist
Price: 4.66 EUR 3.56% Market Closed
Market Cap: 33.6m EUR

Intrinsic Value

The intrinsic value of one LAB stock under the Base Case scenario is 13.15 EUR. Compared to the current market price of 4.66 EUR, Labiana Health SA is Undervalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LAB Intrinsic Value
13.15 EUR
Undervaluation 65%
Intrinsic Value
Price
L
Worst Case
Base Case
Best Case

Valuation History
Labiana Health SA

What is Valuation History?
Ask AI Assistant
What other research platforms think about LAB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is LAB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Labiana Health SA.

Explain Valuation
Compare LAB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LAB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Labiana Health SA

Balance Sheet Decomposition
Labiana Health SA

Current Assets 31.3m
Cash & Short-Term Investments 3.8m
Receivables 14.9m
Other Current Assets 12.6m
Non-Current Assets 23.1m
Long-Term Investments 1.4m
PP&E 13.1m
Intangibles 5.9m
Other Non-Current Assets 2.6m
Current Liabilities 22.1m
Accounts Payable 9.7m
Accrued Liabilities 2.7m
Other Current Liabilities 9.7m
Non-Current Liabilities 27.7m
Long-Term Debt 1.2m
Other Non-Current Liabilities 26.5m
Efficiency

Free Cash Flow Analysis
Labiana Health SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Labiana Health SA

Revenue
70.4m EUR
Cost of Revenue
-27.4m EUR
Gross Profit
43m EUR
Operating Expenses
-36.4m EUR
Operating Income
6.5m EUR
Other Expenses
-5.6m EUR
Net Income
904.4k EUR
Fundamental Scores

LAB Profitability Score
Profitability Due Diligence

Labiana Health SA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive ROIC
Exceptional Gross Margin
Strong 3Y Average Gross Margin
Positive ROE
42/100
Profitability
Score

Labiana Health SA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

LAB Solvency Score
Solvency Due Diligence

Labiana Health SA's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
49/100
Solvency
Score

Labiana Health SA's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LAB Price Targets Summary
Labiana Health SA

Wall Street analysts forecast LAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LAB is 7.14 EUR with a low forecast of 7.07 EUR and a high forecast of 7.35 EUR.

Lowest
Price Target
7.07 EUR
52% Upside
Average
Price Target
7.14 EUR
53% Upside
Highest
Price Target
7.35 EUR
58% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Labiana Health SA
does not pay dividends
Shareholder Yield

Current shareholder yield for LAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one LAB stock?

The intrinsic value of one LAB stock under the Base Case scenario is 13.15 EUR.

Is LAB stock undervalued or overvalued?

Compared to the current market price of 4.66 EUR, Labiana Health SA is Undervalued by 65%.

Back to Top